SELLAS Life Sciences Group Inc (NASDAQ:SLS) price closed lower on Friday, April 12, dropping -4.29% below its previous close.
A look at the daily price movement shows that the last close reads $1.40. The company’s 5Y monthly beta was ticking 2.37. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.91 and 52-week low of $0.50. The stock subtracted -10.07% on its value in the past month.
SELLAS Life Sciences Group Inc, which has a market valuation of $75.40 million, is expected to release its quarterly earnings report May 09, 2024 – May 13, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give SLS a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that SLS’s price is at present 12.44% off the SMA20 and 30.01% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 59.74, with weekly volatility standing at 11.37%. The indicator jumps to 10.91% when calculated based on the past 30 days. SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s beta value is holding at 2.32, while the average true range (ATR) indicator is currently reading 0.13. An analysis of the SELLAS Life Sciences Group Inc (NASDAQ:SLS) stock in terms of its daily trading volume indicates that the 3-month average is 1.38 million.
Current records show that the company has 56.27M in outstanding shares. The insiders’ percentage holdings are 0.69% of outstanding shares while the percentage share held by institutions stands at 9.91%. But the 26.42% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
